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ABSTRACT




Sleep apnea is a disorder, where there are repetitive pauses in respiratory flow of
at least 10 seconds or longer duration, and which occur more than five times per hour.
Apnea has strong modulating effects on the autonomic nervous system, with prominent
heart rate variation. It can be assumed that during sleep, internal influences (sympathetic
and parasympathetic nervous system activities) dominate the autonomic nervous system;
in addition repetitive apneas are accompanied by a pronounced increase in average heart
rate. The aim of this study was to investigate the heart rate variability using spectral
analysis and time-frequency analysis during sleep apnea.
A total of 22 subjects (18 males and 4 females, 49 ± 20 years) were studied who
were experiencing both obstructive sleep apnea and central sleep apnea in whom sleep-
disordered breathing was diagnosed. In addition 6 control subjects were studied where
sleep apnea was not expected. Spectral and wavelet analysis were used to investigate the
heart rate variability from the sleep apnea subjects and control subjects. The results of the
wavelet analysis gave information about the parasympathetic (HF) and sympatho-vagal
balance (LF: HF) changes as a function of time and frequency. The spectral parameters
LF, HF and LF/HF confirmed reduced parasympathetic activity in patients with sleep
apnea compared to normal subjects. In addition the repetitive apneas are accompanied
by a pronounced increased cyclic variation of heart rate.
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1.1 Scope of research
The development of improved treatments for diseased patients is important, and the
development of improved monitoring techniques to assess risk of morbidity and
mortality, as well as to assess response to treatment is needed. One particular population
of patients, which is used in this study, is the Sleep Apnea Hypopnea Syndrome. SAHS
is characterized by repetitive punctuations or reductions of respiration during sleep.
Sleep apnea is a sleep disorder with high prevalence in the adult population. Sleep
apnea is regarded as an independent risk factor for cardiovascular sequelae such as
ischemic heart attacks and stroke. Early recognition and selection of patients with sleep
related breathing disorder is an important task. It has been suggested that this can be
done on the basis of the single channel ECG doing time-frequency analysis [1,20,23].
Sleep apnea / hypopnea syndrome is associated with a wide range of health
implications and increased cardiovascular morbidity and mortality. The gold standard in
diagnosing sleep apnea is polysomnography, an inconvenient, expensive and time
consuming procedure which includes an overnight multi channel recording of blood
oxygen saturation, blood pressure, EEG, ECG, EOG, EMG, nasal/oral airflow, chest
effort, and abdominal effort. This study assesses the suitability of established time-
frequency domain HRV measures, which are known to reflect ANS control [1, 7].
Investigation of heart rate variability during sleep apnea and through tests which
measure the physiologic changes of sleep stage in the brain. However, the effects of
severe sleep disease are not limited to the brain. Often there are serious accompanying
1
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cardiac problems and severe alterations to the normal state of autonomic regulation [1].
Patients with sleep disease are subject to a hyperadrenergic state and have many
alterations in their autonomic physiology that can be documented. There is a non-
invasive measure of autonomic function, heart rate variability (HRV), which can be
performed in a simple fashion and can offer a clear window into the state of the subject.
In subject populations with cardiac disease, the abnormalities found in these measures
were found to have very strong correlations with subsequent mortality and sudden death.
Because of some of the similarities (ex: change in blood pressure, respiration rate etc)
between patients with severe sleep disease and patients with severe heart disease, the
systematic study of the autonomic disturbances in these individuals, along with an
analysis of the survival of the patients with and without treatment should be undertaken
[24].
Respiratory sinus arrhythmia (RSA) is a phenomenon that has been recognized
and studied for years, and it has been described as a rhythmical fluctuation in R-R
intervals that is characterized by a decrease in the R-R interval length during inspiration,
and an increase in the R-R interval length during expiration. Spectral analysis
techniques have allowed researchers to conclude that RSA can primarily be attributed to
vagal activity [1] and can be used as an index of vagal control of the heart. It has been
shown that the variation of blood pressure seen with respiration is also associated with
the heart rate variability. The physiologic mechanism of heart rate variability is
mediated through respiratory afferents synapsing in the medulla oblongata and
entraining the central regulatory oscillator. Similarly, the mechanism of blood pressure
variability (BPV) is entrained to respiration, and is a combination of the effects of the
3
changes of stroke volume and the increase in vagal tone with inspiration. With the use
of spectral analysis, and time-frequency analysis, the raw data (ECG and BP) obtained
can be broken down into useful investigation of sleep apnea subjects [1, 20].
Since the relationship of altered heart rate variability and increased mortality
have been documented in cardiac populations, the population of patients with severe
sleep apnea disease (SA) is an excellent candidate to be studied. Patients with sleep
disease also have significant alterations of their autonomic regulation [1]. In SA patients
breathing patterns are altered, causing abnormalities in the entrainment of the normal
central oscillators.
With the correlations that are possible to see from the previous work that has
been done in cardiac disease and heart failure, it should be possible to demonstrate that
these autonomic tests are clear predictor of HRV in sleep apnea subject.
Further to the above discussion an article survey was conducted, which is discussed
below.
1. Kim [5] reported that HRV was significantly higher in severe apnea patients,
especially in REM and stage 2 sleep. Sleep apnea occurred more in REM
sleep, and exclusively in supine position. The increased HRV during sleep
was excited by sleep apnea. Having more stage 2 and REM sleep can
contribute to higher HRV both in normal and apnea patients.
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2. Penzel [8] compared the results of normal subjects with patients suffering
from mild sleep apnea, modulating influence of sleep stages on heart rate
variability remained very strong even though OSA caused additional
fluctuations. The additional fluctuations are directly linked with the disturbed
respiration during sleep.
3. Hilton [9] reported that spectral analysis of HRV is a better diagnostic than
oximetry for the SAHS. The accuracy of HRV may be reduced with the
association of the other sleep disorders that produce recurrent arousal or
fluctuations in the heart rate. The article proposed that applying spectral analysis
of HRV in conjunction with oximtry would provide much better diagnostic
accuracy then oximetry alone.
4. Baharav [11] reported that the overall increased sympathetic activity during
sleep and sympathetic predominance during SWS in apnea patients, as compared
to control subjects. The degree of sympathetic predominance correlated well
with the severity of sleep apnea.
5. Maier [7] reported that the best result from 28/30 subjects achieved when the
median minute-by-minute values are considered. Calculation over the whole
signal duration decreases the performance considerably, because the higher
regulatory of the cyclic variation of heart rate during period of apnea is blunted
by other fluctuations on this time scale. This author concluded, generally, lower,
less complex heart rate variability is found in apnea patients.
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This study has been designed to answer questions about interactions between the
nervous system, the cardiovascular system, sleep physiology and the pulmonary system;
and issues concerning heart rate variability activity.
6
1.2 Goals and Contributions
The goals of this research are:
1. To apply time-frequency analysis to heart rate variability in order to investigate the
heart rate variability during subject sleep apnea.
2. To use time-frequency analysis to understand and to develop tools that can describe
rapid changes in the time varying spectrum due to apnea. Expansion of the concept of
spectral analysis of heart rate variability to time-frequency analysis gives us the ability
to quantitatively assess the parasympathetic and sympatho-vagal balance changes as a
function of time for the subjects with sleep apnea.
3. To investigate the Weighted coherence which is a technique to measure the total
variance of one signal that is shared with the other signal within a certain frequency
band. It can be computed easily from the values of the coherence function and the
spectral density values of one of the signals in that frequency region.
This work clarified some of the questions about heart rate variability in sleep apnea
subjects which are of fundamental importance in diagnosing the severity of the disease,
in assessing the benefit of rehabilitation procedure and ultimately in determining who
may benefit the most from sleep apnea disease.
7
1.3 Outline of the Thesis
Chapter 1 summarizes the scope of research involving the investigation of sleep apnea
(SA) populations.
Chapter 2 summarizes the physiology background for studying the human
cardiovascular system and sleep mechanism. The description and operating mechanism
of the heart, lung, the electrocardiogram (ECG), the blood pressure, the respiration, the
brain waves and the sleep physiology are presented.
Chapter 3 presents the engineering tools to analyze the biological signals of ECG, BP
and respiration. The basic signal representation used in this thesis is the time-frequency
representation.
Chapter 4 presents the experimental protocols used in the study.
Chapter 5 presents the results of the study.
Chapter 6 presents the discussion of all the results obtained in chapter 5 and conclusions
as well as suggestion of topics for future study. Hopefully, these topics, in addition to
this research work, will motivate the prospective researcher to explore further
unresolved issues in the field of heart rate variability, biological modeling and disease
severity classification in the direction of signal processing application to signal analysis
using time-frequency representation techniques.
CHAPTER 2
PHYSIOLOGY BACKGROUND
Biomedical engineering is the application of the principles of engineering, science, and
mathematics to biology and medicine. The physiological signals or waveforms (ECG,
EEG, blood pressure) are examined because they can yield information of clinical
significance about the biological systems. Therefore, in order to conduct biomedical
research, the relevant physiological systems must be understood. The purpose of this
section is to provide a general, but concise, background to the physiological systems that
are relevant to the work in this research.
2.1 Cardiovascular Systems and the Heart
The cardiovascular system consists of the heart, which is a muscular pumping device,
and a closed system of blood vessels called arteries, veins, and capillaries. The heart
pumps blood around a closed circuit of vessels contained in the circulatory system as it
repeatedly passes through the various "circulations" of the body. The vital role of the
cardiovascular system in maintaining homeostasis is dependent upon the continuous and
controlled movement of blood to reach every cell in the body. Regulation of blood
pressure and flow must change in response to cellular activity. Consequently, numerous
control mechanisms help to regulate and integrate the diverse functions and component




Figure 2.1 The Heart. (From Lauralee Sherwood, Human Anatomy and Physiology, 4 th
Ed. California: The Brooks/Cole Publishing Company, Inc., 2001.)
The heart, illustrated in Figure 2.1, is divided into two functional halves, each
half containing two chambers: an atrium and a ventricle. The atrium of each side
empties into the ventricle on that side. There is no direct flow between the two atria or
the two ventricles in a healthy individual. Blood is pumped by the pulmonary circuit
from the right ventricle through the lungs and then into the left atrium. The blood is then
pumped by the systemic circuit, from the left ventricle, through all the tissues of the
body except the lungs, and then to the right atrium [2].
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Figure 2.2 The Systemic and Pulmonary Circulations. (From Lauralee Sherwood,
Human Anatomy and Physiology, 4 th Ed. California: The Brooks/Cole Publishing
Company, Inc., 2001.)
In both circuits, the vessels carrying blood away from the heart are called arteries
and those carrying blood from either the lung or all other parts of the body back to the
heart are called veins. Figure 2.2 illustrates the heart with the systemic and pulmonary
circulations.
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The heart, located in the chest, is a muscular organ, which is enclosed, in a
fibrous sac called the pericardium. The walls of the heart are primarily composed of
cardiac-muscle cells called the myocardium. Cardiac-muscle cells combine properties of
both skeletal muscle and smooth muscle. However, even more important, approximately
one percent of the cardiac-muscle fibers has specialized features that are essential for
normal heart excitation. They constitute a network known as the conducting system of
the heart and are connected to other cardiac-muscle fibers by gap junctions. The gap
junctions allow action potentials to spread from one cardiac-muscle cell to another [2,
29].
Figure 2.3 The intrinsic conduction system of the heart and succession of the action
potential through selected areas of the heart during one heart beat. B, The sequence of
potentials generated across the heart is shown from top to bottom beginning with the
pacemaker potential generated by the SA node and ending with an action potential.
(From E. N. Marieb, Human Anatomy and Physiology, 3 rd ed. New York: The
Benjamin/Cummings Publishing Company, Inc., 1995.)
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Thus, the initial excitation of one myocardial cell results in excitation of all cells,
and as a result, the pumping action of the heart. The conducting system of the heart is
illustrated in Figure 2.3. The initial depolarization normally arises in a small group of
conducting-system cells called the sinoatrial (SA) node. The SA node is located in the
right atrium near the entrance of the superior vena cava (the vein returning from the body
tissues that are above the heart). The SA node has the fastest inherent discharge rate of
any of the myocardial cells with pacemaker activity. Therefore, the SA node is the
normal pacemaker for the entire heart. The action potential initiated in the SA node
spreads throughout the myocardium, passing from cell to cell by way of gap junctions.
The spread throughout the right atrium and the left atrium does not depend on fibers of
the conducting system. The spread is rapid enough that the two atria are depolarized and
contract at essentially the same time.
The spread of the action potential from the atria to the ventricles involves a
portion of the conducting system called the atrioventricular (AV) node. The AV node is
located at the base of the right atrium. The AV node has an important characteristic that
makes the cardiac cycle more efficient. For several reasons related to the electrical
properties of the cells that make up the AV node, the propagation of action potentials
through the AV node results in a delay of approximately 0.1 seconds. This delay allows
the atria to finish contracting and, therefore, completely emptying their contents of blood
into their respective ventricles before ventricular excitation occurs [2,21].
Upon leaving the AV node, the action potential then travels to the septum, the
area between the two ventricles, by the conducting-system fibers called the bundle of
His. The bundle of His then divides into the left and right bundle branches, which
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eventually leave the septum and enter the walls of their respective ventricles. These
fibers then make contact with the Purkinje fibers, which are large conducting cells that
rapidly distribute the action potential throughout most of the ventricles. The rapid
conduction along the Purkinje fibers and the distribution of these fibers cause the
depolarization of the left and right ventricular cells approximately simultaneously, thus
resulting in a single coordinated contraction. Figure 2.4 illustrates the sequence of
cardiac excitation.
Figure 2.4. The Sequence of Cardiac Excitation (from A.J. Vander, J.H. Sherman, and
D.S. Luciano, Human Physiology, 1994)
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2.2 Blood Pressure
The force that blood exerts against the walls of a vessel is called blood pressure.
Normally, some amount of blood is present in every blood vessel of the body, including
all arteries, arterioles, capillaries, venules and veins.
Blood volume is greatest in the veins. Venous blood pressure, however, is quite
low because of the large-radius and low resistance of the vein. Skeletal movement,
mechanical movement from respiration and one-way valves, facilitates return of
deoxygenated blood to the heart.
Less than fifteen percent of the blood volume is present in the arteries. Mean
arterial pressure, however, is approximately 100 mm Hg. Mean arterial pressure (MAP)
depends upon overall arterial resistance (TPR) and cardiac output (CO) [2]. Specifically:
The resistance of a particular arteriole depends upon the associated organ's
requirements. Under different conditions, an arteriole radius will be varied by control
mechanisms to accommodate the need of the associated organ. If the overall radius of all
arterioles decreases, then the TPR is increased, which may cause arterial blood pressure
to increase, depending upon the CO value.
When blood flows into arteries and arterioles, stretching occurs due to the
pressure that blood exerts on the arterial walls. The maximum pressure, which is
reached when the ventricles eject blood, is called the systolic pressure. The minimum




In the human respiration serves to provide cells with oxygen, eliminate carbon dioxide
and regulate pH of the blood. In order to provide cells with oxygen, air from the
environment enters the body during inhalation. Carbon dioxide and other unwanted
substances are removed from the body during exhalation. Upon inhalation, air enters the
body via the trachea, and then flows into the bronchi. The air then reaches the alveoli.
The properties of the alveoli allow rapid and efficient exchange of gasses between the
blood within the capillaries and the alveoli. The volume of oxygen per unit time ( V02 )
that is transported from the capillaries to the body cells is equal to the volume of the
inspired oxygen that is diffused from the alveoli into the blood at any given instant.
Analogously, the volume of CO2 produced by the body cells per unit time ( VCO2 ) is
equal to the amount of CO2 that diffuses from the blood to the alveoli. The total amount
of air entering and leaving the body per unit time is the called ventilation (VE) [2].
In HRV studies, one important equation that links the circulatory system to the
respiratory system is the calculation of volume of blood ejected from a ventricle during
systole known as stroke volume (SV), which can be derived once VO2 is known [2, 16]:
The physiologic mechanism of heart rate variability is mediated through
respiratory afferents synapsing in the medulla oblongata and entraining the central
regulatory oscillator. Similarly, the mechanism of blood pressure variability (BPV) is
entrained to respiration, and is a combination of the effects of the changes of stroke
volume and the increase in vagal tone with inspiration [2].
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2.4 The Nervous System
Human behavior is controlled and regulated by two major communication systems, the
endocrine system and the nervous system. The nervous system can be divided into two
separate, but interconnected, parts. The first part consists of the brain and spinal cord
and is called the central nervous system. The second part, which consists of nerves,
which extend from the brain and the spinal cord out to all points of the body, is called the
peripheral nervous system.
The peripheral nervous system consists of both an afferent division and
efferent division. The afferent division conveys information from primary receptors to
the central nervous system. The efferent division carries signals from the central nervous
system out to effector cells such as muscles and organs. The efferent division is
subdivided into a somatic nervous system and an autonomic nervous system. The
somatic nervous system consists of all the nerve fibers going from the central nervous
system to skeletal-muscle cells. The efferent innervation of all tissues other than skeletal
muscle is done by the autonomic nervous system. Table 2.1 illustrates the organization
of the human nervous system [1, 2].
Table 2.1 The Nervous System





1. Somatic Nervous System
2. Autonomic Nervous System
a. Sympathetic Nervous System
b. Parasympathetic Nervous System
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2.4.1 The Autonomic Nervous System
Cardiac muscle cells, smooth muscle cells, and glands are innervated by the autonomic
nervous system. Although it is not entirely true, the autonomic nervous system controls
bodily functions that one often assumes to be automatically controlled. Such functions
include heart rate, blood pressure, and body temperature. For example, when one is
placed under a lot of physical stress such as climbing three flights of stairs, the person's
heart rate and respiration rate automatically increase to supply the body with the energy
needed on demand. Likewise, when a person is resting, the heart rate and respiration rate
slow down due to the decrease in energy expenditure. Therefore, one can assume that
the body automatically controls heart rate and respiration rate. However, it is possible to
override the autonomic nervous system and consciously control some of its functions. A
good example of this is that under certain meditation techniques, it has been shown that
some people can actually lower their heart rate substantially below their resting rate, or
even stop their heart from beating for a brief period of time. In addition, some people
can slow their breathing rate to only one breath for every few minutes during deep
meditation.
As shown in Table 2.1, the autonomic nervous system is divided into two
anatomically and physiologically different systems. These two systems are termed the
sympathetic nervous system and the parasympathetic nervous system. Anatomically, the
sympathetic and parasympathetic nervous systems differ for two reasons. One difference
is that the nerve fibers of each system leave the central nervous system at different levels
[1, 2].
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The sympathetic nerve fibers leave the central nervous system from the thoracic
and lumbar sections of the spinal cord. The parasympathetic nerve fibers leave the
central nervous system from the brain through cranial nerves III, V, VII, IX, and X and
the second and third sacral spinal nerves. Cranial nerve X is also called the vagus nerve.
The parasympathetic innervation of much of the thorax and abdomen, and especially the
heart, is done by the nerve fibers, which leave from the brain through cranial nerve X.
Therefore, parasympathetic activity related to the heart is often called vagal activity.
Figure 2.5 illustrates the anatomic difference between the sympathetic nervous system
and parasympathetic nervous system as well as some of their respective effector organs
[2].
The second anatomical difference between the sympathetic and parasympathetic
nervous systems has to do with the location of the ganglia. Each connection of the
autonomic nervous system between the central nervous system and the effector cell
consists of two-neuron chains connected by a synapse. Most, but not all, of the
sympathetic ganglia are located close to the spinal cord and form two chains of ganglia,
one on each side of the spinal cord, called the sympathetic trunk. Conversely, the
parasympathetic ganglia lie within the organs innervated by the postganglionic neurons.
Physiologically, the sympathetic and parasympathetic nervous systems are also
different. One common physiological characteristic is that the major neurotransmitter
released between the pre- and post-ganglionic fibers is acetylcholine. However, in the
sympathetic division, the major neurotransmitter between the postganglionic fiber and
the target cell is usually norepinephrine, a neurotransmitter that activates excitatory
receptors, but in some cases can inhibit certain organs. In the parasympathetic division,
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the major neurotransmitter between the postganglionic fiber and the target cell is the
same as the pre- and post- ganglionic neurotransmitter, acetylcholine. Although
acetylcholine generally has an excitatory effect, it is also known to have inhibitory
effects as well, such as the slowing of the heart by the vagus nerve. In Figure 2.5, it is
important to realize that some organs, such as the heart, eyes, and stomach, receive
autonomic activity from both the sympathetic and parasympathetic nervous systems.
This is often called "dual innervation". Usually, but not always, whatever effect the
sympathetic nervous system has on the effector cells, the parasympathetic nervous
system has the opposite effect.
In general, the sympathetic nervous system increases its response under
conditions of stress. It is responsible for what is known as the fight-or-flight response.
On the other hand, activity of the parasympathetic nervous system is associated with
relaxing and the storing of energy. For example, heart rate increases with sympathetic
activity and decreases with parasympathetic activity. Table 2.2 (Page # 21) summarizes
the effects of the autonomic nervous system on selected organs.
Dual innervation by nerve fibers that cause opposite responses provides a very
fine degree of control over the effector organ- it is like equipping a car with both an
accelerator and a brake. One can slow the car simply by decreasing the pressure on the
accelerator; however, the combined effects of releasing the accelerator and applying the
brake provide faster and more accurate control. Analogously, the sympathetic and
parasympathetic divisions are usually activated reciprocally; that is, as the activity of one
division is increased, the activity of the other is decreased [1, 2].
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In addition to dual innervation, another important physiological characteristic is
that the sympathetic and parasympathetic nervous systems are continually active.
Without these sympathetic and parasympathetic tones, each nervous system would only
be able to produce one desired output, such as increasing heart rate. For instance, when
sympathetic tone increases, heart rate increases. Conversely, when sympathetic tone
decreases below its basal rate, the heart rate will decrease because of less sympathetic
influence.
Figure 2.5 The Sympathetic Nervous System and Parasympathetic Nervous System.
(From E. N. Marieb, Human Anatomy and Physiology, 3 rd ed. New York: The
Benjamin/Cummings Publishing Company, Inc., 1995.)
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Table 2.2 Autonomic Effects on Selected Organs of the Body. (From A.J. Vander, J.H.
Sherman, and D.S. Luciano, Human Physiology, 1994)
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2.4.2 Autonomic Nervous System and Sleep
The parasympathetic and sympathetic nervous system have been regarded as
antagonistic. This behavior is exemplified in end organ responses such as the heart where
an increase in sympathetic activity increases the heart rate while increases in
parasympathetic activity decrease the heart rate. This has resulted in a depiction of the
autonomic nervous system as a balance swinging around a fulcrum.
Sleep is a state of reduced consciousness that offers potential for the assessment
of autonomic regulation in an environment relatively devoid of physical activity and
higher cortical activity. The efferent and afferent systems that may be involved in ANS
regulation in the SAHS are primarily related to the pulmonary and cardiovascular
systems [1].
The normal average heart beat in a resting teen is 70-80 beats per minute, during
sleep it goes down to 50-60 beats per minute, and it accelerate to above 100 with
emotional excitement. During sleep the parasympathetic nervous system is in control and
the sympathetic nervous system is suppressed so that the heart rate becomes low. During
fear the sympathetic nervous system takes command and the parasympathetic nervous
system is suppressed so the heart rate will be higher [1, 2, 29].
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2.5 Heart Rate and Heart Rate Variability
2.5.1 Physiology of Changes in Heart Rate
Change in heart rate is sensitive to changes in body temperature, plasma electrolyte
concentrations and hormone concentrations. However, the most important influence of
beat-to-beat variations of heart rate comes from the autonomic nervous system. More
specifically, sympathetic activity increases heart rate, whereas activity in the
parasympathetic (vagus) nerves causes the heart rate to decrease. Due to considerably
more parasympathetic activity to the heart than sympathetic activity in the resting state,
the normal resting heart rate is below the inherent rate of 100 beats/minute.
The autonomic nervous system innervates the heart in a number of places. The
sympathetic nervous system terminates at the SA node, the conduction system, atrial and
ventricular myocardium, and coronary vessels. The parasympathetic fibers terminate in
the SA and AV nodes, atrial and ventricular musculature, and coronary vessels.
Interplay between the two systems will cause the heart to speed up or slow down,
depending on which system is more active. Figure 2.6 illustrates the autonomic
innervation of the heart [1, 2].
Perhaps the most important site of innervation of the autonomic nervous system
on the heart occurs at the SA node. The SA node possesses an inherent discharge rate,
often referred to as the pacemaker potential. The pacemaker potential is a slow
depolarization of the cells of the SA node. The innervation of the sympathetic and
parasympathetic nervous system on the SA node changes the characteristics of
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depolarization within the SA node cells, thus changing heart rate. Figure 2.7 illustrates
these changes due to autonomic innervation.
Figure 2.6 Autonomic Innervation of the Heart (From M.D. Kamath and E.L. Fallen,
"Power spectral analysis of heart rate variability," Crit. Rev. in Biomed. Eng., 1993)
For comparative purposes, the pacemaker potential labeled "Normal" is the
control. From the figure, one can observe that sympathetic stimulation increases the
slope of the pacemaker potential. As a result, the SA node cells reach the threshold more
rapidly, thus increasing the heart rate. Conversely, parasympathetic stimulation
decreases the slope of the pacemaker potential. Consequently, the SA node cells reach
the threshold more slowly, and heart rate decreases. In addition to decreasing the slope
of the pacemaker potential, parasympathetic stimulation also hyperpolarizes the plasma
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membrane of the SA node cells so that the pacemaker potential starts from a more
negative membrane potential. As a result, the time it takes the SA node cells to reach the
threshold increases, which decreases heart rate [2].
true ""`"1-,
Figure 2.7 Effect of Autonomic Stimulation on the Slope of the Pacemaker Potential
(from A.J. Vander, J.H. Sherman, and D.S. Luciano, Human Physiology, 1994)
2.5.2 Heart Rate Variability as a Measure of Autonomic Function
Changes in heart rate usually involve the reciprocal action of the two divisions of the
autonomic nervous system. An increased heart rate is the result of reduced
parasympathetic tone and a concomitant increase in sympathetic activity. A decrease in
heart rate is usually the result of increased parasympathetic tone and a simultaneous
decrease in sympathetic tone. Therefore, changes in heart rate reflect the action of the
sympathetic and parasympathetic nervous systems on the heart. However, under certain
conditions (emergency or stressful situations), it is possible for heart rate to change by
activity of only one division of the autonomic nervous system, independent of the other
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division, rather than reciprocal changes in both [1, 2]. This response is typically referred
to as a fight-or-flight response.
Initially, the effect of the autonomic nervous system on the heart was estimated
by utilizing the traditional technique of average heart rate. As a reference, the average
heart rate was measured under normal resting conditions. Then the average heart rate
was measured under the administration of drugs. The drugs used were atropine, which
blocks the effects of the parasympathetic nervous system, and propranolol, which masks
the effects of the sympathetic nervous system. A qualitative assessment can then be
made of the autonomic nervous system by comparing the reference heart rate to the heart
rate while under the administration of the drugs. This method looks at the average over
time of heart rate. However, when the ECG is looked at on a beat-to-beat basis, rather
than over a period of time, fluctuations in the heart rate are observed. Recent research
indicates that fluctuations in heart rate are a healthy sign. In fact, one hypothesis is that
the larger variations in the heart rate correlate to a healthier autonomic nervous system.
By contrast a number of physiologic and disease states produce alterations in autonomic
function, which reduce the variability in heart rate.
The direct quantification of vagal activity in humans is difficult as recording directly
from the nerve is highly invasive. The degree of RSA provides a quantitative measure of
the vagal outflow to the myocardium. That is, the phasic inhibition of cardiac vagal
activity associated with inspiration produced by the CNS introduces a heart rhythm at the
respiratory frequency, typically 0.25Hz [1, 18]. The amplitude of this rhythm (i.e. the
degree of slowing down and speeding up) of the heart rate determines the tonic level of
the vagal outflow. Spectral analysis techniques have been applied to the heart rate
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variability (HRV) in order to estimate the frequency component centered about the
respiratory frequency, termed the high frequency band (HF). This evaluation of RSA has
provided a useful method for the non-invasive measurement vagal input to the
myocardium.
The heart rate demonstrates a frequency component at a lower frequency (LF)
centered at about 0.1Hz (i.e. one cycle per 10 seconds). These slower cycles, related to
sympathetic activity, have been associated with Mayer waves and baroreceptors [18].
There is a certain amount of disagreement as to the physiological significance of the LF
component of HRV, because pharmacological interventions blocking the vagus also
produce a reduction in LF power in HRV studies. Thus, the LF variability is thought to
have both a sympathetic and vagal component and is not a pure measure of sympathetic
activity. The sympathetic nervous system modulates blood pressure Mayer waves. The
cyclical increases in blood pressure most likely modulate the heart rate via baroreceptor
feedback mechanisms. A better concept that is used to isolate the sympathetic activity is
that of "sympatho-vagal balance" which recognizes both reciprocal and non-reciprocal
parasympathetic and sympathetic influences on heart rate by computing the low
frequency to high frequency ratio. An increase in the low frequency to high frequency
ratio indicates either an increase of sympathetic activity, a decrease in parasympathetic
activity, or a reciprocal change in both.
Power spectrum analysis of short segments of beat-to-beat heart rate variability
(PS/HRV) reveals three distinct peaks. In human PS/HRV, the high frequency (HF) band
(0.15 to 0.4 Hz) is correlated with respiratory driven vagal efferent input to the sinus
node. The low frequency band (LF) 0.06 to 0.15 Hz is believed to be due to baroreceptor
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mediated blood pressure control. Therefore, PS/HRV represents a noninvasive signature
of the balance between sympathetic and parasympathetic components of the autonomic
nervous system.
2.6 The Electrocardiogram
The electrocardiogram (ECG) is primarily a tool for evaluating the electrical events
within the heart. The action potentials of cardiac muscles can be viewed as batteries that
cause charge to move throughout the body fluids. These moving charges, or currents,
represent the sum of the action potentials occurring simultaneously in many individual
cells and can be detected by recording electrodes at the surface of the skin. Figure 2.8
illustrates a typical normal ECG recorded between the right and left wrists for one
heartbeat [2, 29].
Figure 2.8 An electrocardiogram tracing (lead I) illustrating the three normally
recognizable deflection waves and the important intervals. (From E. N. Marieb, Human
Anatomy and Physiology, 3 rd ed., 1995.)
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The first deflection, the P wave, corresponds to the current flow during atrial
depolarization (contraction). The second deflection, the QRS complex, is a result of
ventricular depolarization. The third and final deflection is the T wave. The T wave is a
result of ventricular repolarization (relaxation). It should be noted that atria
repolarization is usually not evident in the ECG because it occurs at the same time as the
QRS complex.
As mentioned earlier, the ECG is a measure of the electrical activity of the heart
measured on the skin. In order to measure the ECG, bipolar leads are required. The
bipolar method of acquiring ECG detects electrical variations at two different locations
on the skin and displays the difference to obtain one waveform. Figure 2.9 is an
illustration of the standard limb lead connections that form the Einthoven's triangle. In
addition, the diagram also shows the names of the respective leads. To record lead I, the
negative terminal of the ECG monitor is connected to the right arm (RA) and the positive
terminal is connected to the left arm (LA). To record lead II, the negative terminal of the
ECG monitor is connected to the right arm and the positive terminal is connected to the
left leg. To record lead III, the negative terminal of the ECG monitor is connected to the
left arm and the positive terminal is connected to the left leg (LL). The reference point
or ground is connected to the right leg (RL) [2, 29].
It is important to realize that depending on where the electrodes are attached, a
different waveshape will be obtained for the same electrical events occurring in the heart.
In other words, leads I, II, and III all have a different waveform shape. In addition to
obtaining different waveforms depending on the location of the electrodes, each
individual has a unique ECG.
Figure 2.9 The placement of the positive and negative electrodes for three commonly
used leads, as shown. (From J. G. Creager, Human Anatomy and Physiology. Belmont,





The gross electrical activity of different parts of the brain can be recorded
electrographically. Extracellular current flow arising from electrical activity within the
cerebral cortex can be detected by placing recording electrode on the scalp to produce a
graphical record known as an Electroencephalogram or EEG. These "brain waves" for
the most part are not due to action potentials but instead represent the momentary
collective postsynaptic potentials activity in the cell bodies and dendrites located in the
cortical layer under the recording electrode [2, 8, 29].
As mentioned briefly in the previous section, electrodes placed on the scalp measure
continuing oscillations due to the electrical activity of the brain. These variations in
potential are called brain waves, and when they are recorded, the record is termed an
electroencephalogram. The amplitude of these waves when measured through the scalp
is about 10-100microVolt, and their frequency can vary from 0.5Hz to 100Hz. The
character of the brain waves is highly dependent on the degree of activity in the cortex.
Much of the time, especially during alert activity, the brain waves are small in amplitude
and quite asynchronous. However, at other times the brain will exhibit very rhythmic
activity that is almost sinusoidal in nature.
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2.7.2 Brain Wave During Sleep
The brain wave patterns are divided into four different types of waves: alpha, beta, theta
and delta waves [1, 2].
Alpha waves consist of high-amplitude, well-synchronized sinusoidal waves having a
frequency of between 8 and 12 Hz. They occur in almost all adults, particularly in the
thalamocortical region of the brain, when they are awake but in a quiet, resting state with
eye closed. Alpha waves will disappear during sleep and when an awake person focuses
attention on a specific mental activity.
Beta waves are desynchronized, and lower-amplitude then alpha waves.
Desynchronization is not only characteristic of the transition between the closing and the
opening of the eyes, but also of the most alert, attentive, or excited states. Beta waves
normally occur at frequencies above 13 Hz; sometimes they can be as high as 50Hz.
These mostly appear in the parietal and frontal lobes during intense mental activity.
Theta waves oscillate at frequencies between 4 and 7Hz. These waves occur mainly in
the parietal and temporal lobes of children, but they can also appear during emotional
stress in adults, especially during disappointment and frustration.
Delta waves include all frequencies below 4Hz. These occur in very deep sleep, in
infants, and in serious organic brain disease. They also have occurred in animals whose
cerebral cortex has been transected from the thalamus, indicating the waves can occur in
the cortex independent of other brain areas.
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2.8 Sleep Physiology
Currently there can be no absolute definition of sleep. In the human, sleep and sleep
type is identified by electroencephalographic (EEG) frequency. This does not extend
to all organisms as the simplest single cell organisms demonstrate rest-activity cycles
[1].
The exact function of sleep is still to be definitively elucidated. Many theories have
abounded as to the function of sleep [1]. These are include but are not limited to
1. Energy conservation (save energy, stop expenditure)
2. Wakefulness (being awake)
3. Immune function
4. Growth (in children, repair work in adults)
5. Data storage (reverse learning)
2.8.1 Sleep
In the human being sleep is differentiated into two main types namely:
1. Rapid Eye Movement (REM) and
2. Non-Rapid Eye Movement (NREM).
REM sleep has been divided into two principal classes namely phasic (high
amplitude, low frequency) and tonic (low amplitude, high frequency) REM. NREM
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sleep is characterized by four main sleep stages ranging from light sleep: stages1 and
2 sleep to deep sleep: stages 3 and 4 sleep. In humans the temporal arrangement of
sleep type is described graphically by a hypnogram (Fig: 2.9.1)
HOURS OF SLEEP
(Fig: 2.9.1) Typical Hypnogram from a healthy young subject.
Typically humans transition from quiet wakefulness into stage 1 sleep that lasts for 1
to 7 minutes, followed by a rapid progression taking between 10 and 25 minutes,
through sequential NREM sleep stages to stage 4 sleep. REM sleep then follows deep
sleep. This NREM-REM sleep cycle has an ultradian rhythm of approximately 90
minutes. As the sleep episode progresses this 90-minute cycle repeats; however the
density of each sleep type alters across the course of time into sleep. Deep sleep
(stage 3 and 4) is most prominent in the early part of the night and is related to
homeostatic sleep pressure influences. Thus, as the sleep drive is progressively
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satisfied across the course of the night, the time spent in deep sleep decreases. REM
sleep exhibits the reverse pattern. The first episode of REM sleep may be as short as
a couple of minutes lengthening to approximately 20-30 minutes by the end of the
sleep episode [1, 2].
2.8.2 Types of Sleep — Sleep Stages
A methodology for the identification of human sleep stages uses their recognizable
electroencephalograph (EEG) characteristics.
Wakefulness
The first stage is wakefulness which is characterized by low amplitude
desynchronized EEG in the eyes open state. Relaxed wakefulness with the eyes
closed may contain alpha rhythm.
Stage 1 Sleep
Stage 1 sleep is generally low amplitude EEG with some theta rhythms and vertex
waves (sharp negative waves). Transitions into sleep are identified by alpha-theta
transitions. There may also be slow rolling eye movements in stage 1 sleep.
Time in seconds.
(Fig: 2.9.2) Stage 1 sleep — Alpha.
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(Fig: 2.9.3) EEG during sleep stage 1.
Stage 2 Sleep
During stage 2 sleep the EEG becomes more synchronized and is characterized by the
appearance of K-complexes (a sharp negative wave followed by a slower positive
component) and sleep spindles (short rhythmic waveform clusters of 12 — 14Hz). If a K-
complex or spindle is present then it is stage 2 sleep. However stage 2 sleep can be
scored in the absence of K-complexes and spindles if it is surrounded with other episodes
of stage 2 sleep and has the characteristics frequency components. There may also be
slow rolling eye movement.
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(Fig: 2.9.4) EEG sleep stage 2.
Slow Wave Sleep
Both stage 3 and 4 sleep are characterized by EEG delta wave activity. Delta waves
are large amplitude waves at a frequency of < 4Hz. Stage 3 has >20% and <50%
delta waves, stage 4 has >50% delta waves. There is usually little to no eye
movement present in deep sleep.
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Time in seconds.
(Fig: 2.9.5) EEG slow wave sleep during stage 3&4.
Rapid Eye Movement Sleep (REM)
REM sleep exhibits some of the characteristic traits from both sleep and wakefulness
EEG recordings. The EEG in REM is low amplitude and desynchronized. It may exhibit
a saw tooth pattern [1, 2].
REM can also be broadly classified in to two types namely phasic and tonic
REM. During phasic REM there are rapid eye movements and brief bursts of EMG,
while during tonic REM eye movement are not present.
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(Fig: 2.9.6) EEG - REM sleep.
2.9 Sleep Apnea Disease (SA)
Apnea has been described as a total cessation in airflow for a period of greater
then 10 seconds. As the apnea continues to progress there is an absence or reduction of
alveolar ventilation. Hypopnea is a reduction in airflow of greater then 50% for a period
of 10 seconds or greater with apnea being the extreme case of hypopnea. The sleep apnea
/ hypopnea syndrome (SAHS) is characterized by repetitive pauses in respiration during
sleep. The literal Greek meaning of "Apnea" is "want to breath". A syndrome is defined
by " a group of concurrent symptoms of a disease". Conservative prevalence studies
estimate that 4% of males and 2% of females have the SAHS in American population. It
is considered a major health problem having been reported as a more serious public
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health problem than smoking and asthma. It has also been reported that the SAHS
contributes to road traffic accidents, memory impairment and personality changes [1].
2.9.1 Symptoms
Interruptions of the normal respiratory cycle, due to apnea or hypopnea, typically end
with an arousal, which fragments the normal sleep architecture. This arousal-arousal
cycle potentially causes a daytime neurological disorder of excessive daytime sleepiness,
impaired cognitive function, short-term memory impairment and mood swings. Other
associated symptoms include snoring, nocturnal enuresis, nocturnal choking,
unrefreshing sleep, morning headaches, impaired sexual function, spouse reports of
arousal and restless sleep. Typically, but by no means always, a patient with the SAHS is
an obese, middle-aged male presenting with excessive snoring and excessive daytime
sleep (EDS) [1, 20].
2.9.2 Severity of Sleep Apnea
The severity of sleep apnea is classified according to the number of times per hour that a
person stops breathing (apnea) or has slowed breathing (hypoapnea). Periods of apnea
must result in at least a 4% drop in blood oxygen levels. The classification is referred to
as the apnea-hypoapnea index (AHI) [1, 20].
• Mild Apnea. Mild apnea is 5 to 15 episodes of apnea or slowed breathing
per hour with 86% or more oxygen saturation in the blood. Symptoms may
include drowsiness or falling asleep during activities that do not require
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much attention, such as watching TV or reading. These symptoms may
cause only minor problems with work or social function.
• Moderate Apnea. Moderate apnea is 15 to 30 episodes of apnea or
hypoapnea per hour with 80% to 85% oxygen saturation in the blood.
Symptoms may include drowsiness or falling asleep during activities that
require some attention, such as attending a concert or a meeting. These
symptoms may cause moderate problems with work or social function.
• Severe Apnea. Severe apnea is more than 30 episodes of apnea or
hypoapnea per hour with 79% or less oxygen saturation in the blood.
Symptoms may include drowsiness or falling asleep during activities that
require active attention, such as eating, talking, driving, or walking. These
symptoms may cause severe problems with work or social function.
2.9.3 Types of Apnea
An apnea may arise from different mechanisms. This has led to the sub-classification of
apnea types. The most common cause of an apnea event is the result of mechanical
obstruction of the upper airway. This is termed an obstructive sleep apnea event. A
narrow, floppy upper airway provides the pathophysiological basis for OSA. This may
have a congenital or acquired origin. Usually such an airway does not cause problem
during wakefulness. However, with sleep the associated loss of skeletal muscle tone
increases the collapsibility of the upper airway [15], particularly during rapid eye
movement (REM) sleep when muscle relaxation is profound. This has two important
consequences as gas is accelerated through it. First, the structures will tend to vibrate as
42
turbulent flow patterns are produced, with snoring the result. Second, the pharynx will
tend to collapse due to the Bernoulli effect, with resultant partial or complete
obstruction. Obstruction will persist until sleep is interrupted and muscle tone is restored.
Usually these interruptions are momentary arousals lasting less then 15 s and the sufferer
is unaware of them. Occasionally, the obstructive event will result in an awakening, and
the sufferer may complain of waking suddenly or with a snort or a snore. With arousal,
breathing is restored and after a few breaths deeper sleep will resume with recurrence of
the problem as the muscles again relax. In the more severe cases of OSA, this cycle of
apnea and arousal may occur hundreds of times a night. In the more subtle cases, it may
only occur in certain sleep stages (particularly REM sleep) and postures (particularly
supine) or after alcohol consumption. The result of this constant sleep disruption is
lethargy and somnolence during wakefulness [1, 2, 15, 20].
(Figure: 2.9.7) illustrates an obstructive apnea where airflow is discontinued however;
intrathroracic movement indicates the presence of a respiratory effort.
(Fig: 2.9.7) Obstructive Sleep Apnea.
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An apnea that results from loss of central respiratory drive is termed a central apnea.
During a central apnea there is little to no chest or abdominal wall expansion; therefore,
no negative intrathoracic pressure developed during the apnea. A central apnea resulting
from Cheyne-Stokes respiration (periodic breathing) in a heart failure patient, is
illustrated in (Fig: 2.9.8) [1. 16. 19. 201.
(Fig: 2.9.8) Central Sleep Apnea example. The top tracing illustrates tidal volume (VT); the middle trace
in the intrathoracic pressure recording (Pes) and the bottom trace illustrate the corresponding arterial
oxyhaemoglobin saturation (SaO2).
There is also a hybrid type of apnea termed a mixed apnea. Mixed apneas begin centrally
and the upper airway collapses. Then respiratory efforts begin against the occluded
airway, turning it into an obstructive event. Hypopneas are not usually sub-classified
through they result from the same combination of mechanisms as apneas.
Table: 2.3 Symptoms Associated with Sleep Apnea
Adults Children
Heavy snoring Snoring
Excessive daytime sleepiness Restless sleeping
Witnessed apneas Somnolence
Sudden awakenings with "choking" Aggression / behavioural problems
Accidents related to sleepiness Hyperactivity
Poor memory/concentration Odd sleeping postures




Dry mouth on awakening
Nocturnal or morning headache
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2.9.4 Physiological Changes during an Apnea
Hemoglobin Saturation
The reduction in alveolar ventilation resulting from either an apnea or hypoapnea
event may, but not always, produce a decline in arterial oxyhaemoglobin saturation
(Sa02). Apneas are more likely to produce an arterial desaturation than hypoapneas [1].
Arousals
Respiratory disturbances typically end with cortical arousals. Arousals are characterized
by an increase in EEG frequency. Brief arousals, lasting less than 15 seconds, are termed
micro arousals. Definitions of EEG arousal classification vary. The most widely applied
criteria for arousal are those reported by the American Sleep Disorders Association
(ASDA). The ASDA criteria define a duration of 3-seconds for an arousal to be scored.
Several reports have noted that not all respiratory events are terminated with a visually
identifiable cortical arousal. Davies et al [33]. have shown that auditory stimuli provoke
heart rate and blood pressure alterations without noticeable EEG changes. Conclusions
drawn from this work have generated the concept of subcortical or autonomic arousals.
These may provide a quantifiable method for measurement of sleep disruption.
Heart Rate
Inspiratory efforts against an occluded upper airway produce large negative intrathoracic
pressure swings (Fig: 2.9.9). This is akin to performing the Mueller manoeuvre
(voluntary negative intra-thoracic pressure), which is known to cause vagal activation.
This is illustrated in the bottom trace of (Fig: 2.9.7) where a lengthening of the R-R
intervals in the ECG trace is witnessed during the apnea. Supporting evidence for vagal
involvement producing the apnea related bradycardia is that atropine sulphate inhibits
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this reflex. Hedner et al [1]. report that, during an apnea, there is increasing muscle
sympathetic nerve activity, peaking immediately prior to apnea cessation. The effect of
increased sympathetic stimulus during an apnea, usually increasing the heart rate, may be
swamped by the concurrent increase in vagal activity.
(Figure: 2.9.9) Transient heart rate and blood pressure consequences of an apnea.
The arousal at the termination of an apnea initiates a burst of sympathetic activity. In the
SAHS, transient sympathetic increases have been demonstrated by blood pressure, heart
rate (Figure: 2.9.9), catecholamine and MSNA recordings. The resulting tachycardia at
arousal is not completely abolished by pharmacological Beta-blockade suggesting that
there may be vagal inhibition in addition to sympathetic activation. In addition, at
arousal there is reported carotid body activation and baroreceptror inhibition. After the
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arousal heart rate and sympathetic activity fall to near resting levels [1, 15, 16], which
can be seen in our data (Fig: 2.9.9.1). The first waveform shows the airflow of a 10
second apnea period. The following two graphs are electrocardiograph with the
lengthening of the R-R intervals and simultaneous increase in blood pressure during the
apnea. After the arousal the heart rate and blood pressure fall to near resting levels.
.1.114.1V 	 seconds .
(Fig: 2.9.9.1) Airflow, heart rate and blood pressure consequences of an apnea
Blood Pressure
Systemic and pulmonary arterial pressure increase during an apnea. By the termination
of an apnea, blood pressure can increase, with an associated decrease in stroke volume
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suggesting an increase in peripheral resistance [1]. Following an apnea, blood pressures
return to normal.
Haemodynamics Effects
It has been suggested that the negative intrapleural pressures developed during apnea
induces homodynamic changes in the myocardium and shifts in thoracic blood volume.
It is unlikely that the blood pressure alterations are due to mechanical hemodynamic
changes as studies have demonstrated that central apnea events, where no respiratory
effort is produced, elicit blood pressure increases and bursts of muscles sympathetic
nerve activity. Non-apnea arousals, i.e. those produced by nocturnal myoclonus (shock-
like muscle contraction) and auditory stimuli also yield increases in systemic blood
pressure and heart rate [1, 2, 20].
CHAPTER 3
ENGINEERING BACKGROUND
The purpose of this chapter is to introduce a brief background of signal-
processing methods used in this study. One major component of this thesis is the
investigation of heart rate variability using wavelets. The rest of this chapter will
present the reason for using time-frequency analysis, the background on wavelets and
the general approach to computing time-frequency distributions.
3.1 The Need for Time-Frequency Distributions
The distribution of signal energy in time and the distribution of signal energy in
frequency are very straightforward. The distribution in time is defined as the squared
magnitude of the signal,  , and the distribution in frequency is defined as the
squared magnitude of the Fourier transform, |X(ω)|^2 Neither the signal nor its Fourier
transform indicate how the energy of the signal is distributed simultaneously in time and
frequency [17, 18].
3.2 The Uncertainty Principle
The uncertainty principle in time-frequency analysis provides us with a lower limit on
the spread of signal energy in time and frequency. To define the spread of a signal in
time and frequency, we first need to define the average time μ t and average frequency
pa, of a signal:
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The spread of the signal in time a 2 (duration) and frequency o (bandwidth) is defined
as:
Therefore a signal cannot have an arbitrarily small duration and bandwidth. A Gaussian
signal:
meets this bound with equality where a is an arbitrary constant.
3.2.1 The Analytic Signal and Instantaneous Frequency
Most signals are real valued functions of time. Since the Fourier transform of a real
signal will be even, there is an unnecessary redundancy in a real signal. To eliminate the
redundancy, one can compute what is called the "analytic signal" from the real valued
signal. The analytic signal, xa (t) , is of the form:
where H[] is the Hilbert transform operator . The Fourier transform of the analytic
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One advantage of the analytic signal is that it can be sampled at half the rate of the real
signal. Another advantage of the analytic signal, which will be discussed later, is that
there are fewer cross terms in the time-frequency distribution of an analytic signal.
In computing examples of time-frequency distributions, we will often use narrow band
signals of the form:
The above is the analytic signal corresponding to A(t) cos(φ(t)) . The frequency of a
signal at a given time is denoted as the instantaneous frequency, and for the signal in
equation 3.1 it is defined as [13, 17, 18]:
where 8(.) is a Dirac delta function. The above equation implies that the energy of the
time-frequency distribution is concentrated along the instantaneous frequency of the
signal. A dual quantity is the average time of a signal at a given frequency. This
quantity is called the group delay. For a signal of the form:
the group delay is defined as:
3.2.2 Properties of Time-Frequency Distributions
There are many methods for constructing time-frequency distributions. To provide
guidelines for constructing time-frequency distributions, authors have proposed many
"desirable" properties that time-frequency distributions should satisfy. For example,
since time-frequency distributions are usually considered to be energy distributions, they
should be real and positive functions. Also, the time marginal of a time-frequency
distribution is the integral of the time-frequency distribution over frequency, and the
time marginal should be identical to the distribution of signal energy over time.
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3.3 Power Spectral Analysis of Heart Rate Variability
Power spectral analysis of heart rate variability is a potentially powerful tool for
evaluating the activity of the autonomic nervous system non-invasively. Power spectral
analysis is a technique, which transforms a signal from the time domain to the frequency
domain. It is based on the theory proposed by Fourier who states that all periodic
functions can be represented as a sum of sines and cosines at a fundamental frequency
and its harmonics. This sum is referred to as a Fourier series. Since heart rate
variability is not periodic, a similar technique called the Fourier transform is applied.
The time domain signal used for computing the heart rate variability power spectrum is
known as the interbeat interval (IBI)[17, 18].
The ECG and BP signals are converted from analog to digital form and stored in
.TXT format on the data acquisition computer. The data is then transferred over to a
signal-processing computer. A LabVIEW program is used to identify the channel and
obtain the HRV power spectrum. The following is a description of the necessary steps
to obtain the power spectrum of HRV.
The first step to obtain the power spectrum of HRV is to detect every R-wave in
the ECG. Because the R-wave complex is more pronounced in the ECG the LabVIEW
detection program can easily detect these R-waves.
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Figure 3.1 Figure Depicting the Construction of the IBI Signal (from S.J. Shin, W.N.
Tapp, S.S. Reisman, and B.H. Natelson, "Assessment of autonomic regulation of heart
rate variability by the method of complex demodulation," 1989)
Before trying to detect the R-waves, the ECG signals are detrended using a
locally weighted robust regression algorithm built in LabVIEW. To help detect each R-
wave, a vertical threshold (which the R-wave must exceed) and a horizontal threshold
(to prevent detecting an R-wave for a period of time after one was detected) can be
varied. If an error occurs during the R-wave detection, the analyst can use existing
software to manually detect or the mis-detected R-waves.
Once the R-waves are properly detected, an interbeat interval (IBI) signal can be
constructed. To obtain the IBI signal, the distance in time between a specific beat (TO
and the beat previous in time ) is calculated. This value of time difference then
becomes the amplitude of the IBI signal at that specific beat. Mathematically, the IBI
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signal is computed by the formula IBIm=Tm - Tm-1. See Figure 3.1 for a graphical
representation.
Although the IBI represents the heart period at discrete points, the IBI signal is
not suitable for FFT analysis because the discrete points, located at each R-wave, are not
evenly spaced. In order to produce equidistant IBI samples suitable for analysis, the IBI
signal must be interpolated. The interpolation method used was that of a backward step
function. This method assumes no new information about the direction of the time
series is available until the next heartbeat occurs. Therefore, the amplitude of all of the
interpolated values between a beat at timeTm-1, and the beat at T„,, were set equal to the
time difference between Tm and Tm-1 l . The interpolated interbeat interval (IIBI) is then
sampled to produce an IIBI with evenly spaced samples. For example, in Figure 3.1(c)
if a beat occurs at a time equal to 2 seconds and the next beat occurs at a time equal to
2.9 seconds, then the interpolated values between time 2 seconds and 2.9 seconds are all
0.9 as shown in Figure 3.1(d). After the IIBI signal is obtained, it is detrended using a
locally weighted robust regression algorithm (available in LabVIEW), which acts like a
filter. Essentially, this removes low frequency components below .05 Hz. If these low
frequency components are not removed, they can dominate the power spectrum and
decrease the detail of the components in the frequencies above 0.05 Hz. Another
example of an IBI signal and an IIBI signal is shown in Figure 3.2.
Figure 3.2 IBI and IIBI Signals of heart rate.
The final step to obtain the power spectrum of HRV is to take the FFT of the
detrended IIBI signal. In the existing software, this is done by decimating the IIBI signal
by a factor of ten (the ECG is sampled at 200 Hz) and taking an 8192 point FFT of the
decimated IIBI signal. When the signal is decimated by a factor of ten, every tenth point
of the original signal is kept, and the nine points in between every tenth point are not
used. In a time series of samples, every tenth point occurs at the same time as in the
undecimated signal, except that there are no samples in between. In effect, decimating is
similar to down-sampling. Because the length of the IIBI signal is approximately the
same length of the sampled ECG, which is acquired using a sampling frequency of 200
Hz, decimating the IIBI by a factor of 10, is similar to sampling the IIBI at 20 Hz. This
can be done because the IIBI signal contains no frequency components above 6 Hz.
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The software is programmed to take an 8192-point FFT by default regardless of
the input signal length. In our experiments, —300 seconds of ECG were collected. At a
sampling frequency of 200 Hz, this corresponds to 60,000 samples. Recall that the IIBI
is approximately the same length as the ECG. If an 8192-point FFT were taken, only the
first one-eighth of the IIBI would be represented in the spectrum. In addition, the
frequency resolution would be 200/8192= 0.0244 Hz and the spectrum would be
between 0Hz and 100 Hz. However, the spectrum of the IIBI, the heart rate variability
spectrum, consists of low frequencies less than 6 Hz; therefore, the spectrum does not
need to be calculated up to 100 Hz. As a result, the IIBI is decimated by a factor of ten.
In this case, the IIBI signal would then be 6,000 samples long for a 300-sec long ECG
signal. For example the length of the IIBI signal is 6,000 points long. The length of the
IBI signal depends on the number of heartbeats. Now, in order to take an 8192-point
FFT of a signal that has only 6,000 samples, a technique called zero padding must be
used. Essentially all samples from 6001 to 8192 are given the value of zero. The only
effect this has on the spectrum is that it increases the frequency resolution. When the
FFT is calculated, we limited our spectrum from 0 Hz up to 10 Hz. The frequency
resolution is now 20/8192=0.00244 Hz. Once the power spectrum is obtained, it is
smoothed twice by applying a modified Daniell Rectangular smoothing algorithm.
Figure 3.3 illustrates the power spectrum of the IIBI signal in Figure 3.2.
Figure 3.3 Power Spectrum of IIBI Signal in Figure 3.2.
It should also be noted that when performing the FFT, the IIBI signal is
windowed by applying a split cosine bell taper. The taper begins at 20 percent from
each end of the time signal. The application of the split cosine bell taper is done before
the zero padding takes place so as to provide a smooth transition to zero rather than the
window's abrupt changes from one to zero.
It should be noted that if the window were a simple rectangular function, the
sharp one to zero changes are the cause of the side lobes in the FFT output sine function
(sin(x)/x). To minimize the spectral leakage caused by those sidelobes, we have to
reduce the sidelobe amplitudes by using window functions other than the rectangular
window. The purpose of the split cosine bell taper window is to reduce any additional
spectral components that result from the shape of the window. Multiplying the time
signal by the window function does the windowing. The split cosine bell taper for a
6,000-point long signal is shown in Figure 3.4.
Figure 3.4 Plot of the Split Cosine Bell Taper used as a Window in the F'FT Calculation
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Past research in power spectral analysis of heart rate variability correlates the
three distinct peaks with certain physiological parameters as illustrated by a more
classical power spectrum of the IIBI signal in Figure 3.5. The very low frequency band
is associated with vasomotor control and temperature control. The low frequency band
is associated with baroreceptor-mediated blood pressure control. The high frequency
band has been linked with respiration [18].
Figure 3.5 Example of power spectral density of HRV. Blue: power of spectrum of RR
interval in VLF range, red: power in LF range and yellow: power in HF range. (From
www. skyaid.org/Skyaid%20Org/Medical/HRV_Courses.htm,  2001)
To date, the best-known and best-defined peak in power spectral analysis of
heart rate variability is the high frequency peak. The high frequency peak reflects
changes in the interbeat interval that cycles up and down at the same frequency as
respiration. This influence of respiration on heart rate has been known for more than
one century and is called respiratory sinus arrhythmia (RSA). Properly defined, RSA is
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a rhythmical fluctuation in heart periods at the respiratory frequency that is characterized
by a shortening and lengthening of heart periods in a phase relationship with inspiration
and expiration, respectively. RSA is being used increasingly as a measure of vagal
control of the heart. As a result, the high frequency peak, which often occurs at the
same frequency as the respiration peak, corresponds approximately to the RSA and it is
purely parasympathetic in origin. From experience, one might contest that the frequency
of respiration is not limited to within the narrow band of 0.15 Hz to 0.4 Hz. The normal
respiration rate can be as low as only a few breaths per minute at rest and as high as up
to 40 breaths per minute during intense exercise. This stresses the fact that, when doing
research on heart rate variability to determine parasympathetic activity, the frequency of
respiration must be known. More specifically, the power spectrum of the respiration
waveform should be computed. [13, 17, 18].
Unlike parasympathetic activity, the sympathetic activity is not easily separated
from the power spectrum of heart rate variability. It has been hypothesized that the low
frequency peak (0.04 to 0.15 Hz) is a mixture of both parasympathetic activity and
sympathetic activity. A better concept that is used to isolate the sympathetic activity is
that of "sympatho-vagal balance" which recognizes both reciprocal and non-reciprocal
parasympathetic and sympathetic influences on heart rate by computing the low
frequency to high frequency ratio. An increase in the low frequency to high frequency
ratio indicates either an increase of sympathetic activity, a decrease in parasympathetic
activity, or a reciprocal change in both.
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3.4 Wavelet Transforms
Analysis of signals using appropriate basis functions is one of the fundamental problems
in the signal processing field. Fourier proposed the complex sinusoids as the basis
functions for signal decomposition. The Fourier transform of a finite energy continuous
time signal f (t) , (i.e. f (t) E L2 ) is defined as [14, 22]:
The strength of the standard Fourier analysis is that it allows the decomposition of a
signal into its individual frequency components and establishes the relative intensity of
each frequency component. Because of the infinite durations of these basis functions,
any time-local information (e.g. an abrupt change in the signal) is spread over the whole
frequency spectrum. Therefore, this transform cannot reflect any time-localized
characteristic of f (t) into frequency domain. It only provides the frequency behavior of
f (t) in the interval -00< t<00. Gabor addressed this problem by introducing a window
function to localize f (t) and calculating the Fourier transform of the windowed signal
as
where ω(t-τ) is the appropriate time-frequency localized, window function. This
transform is called the Windowed or Short-Time Fourier Transform (STFT) (also
referred to the Gabor transform when the window function used in the STFT is
Gaussian) [13, 14, 22].
The major advantage of Short-Time Fourier Transform is that if a signal has
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most of its energy in the given time interval [-T,T] and in the frequency interval
[– Ω,Ω], then its STFT will be localized in the region [-T,T]x [– 0,0] of the time-
frequency plane. Of course, the uncertainty principle prevents the possibility of having
arbitrary high resolution in both time and frequency domains, since it lower-bounds the
time bandwidth product of any basis function by Ann —1 where (0T) 2 and
4r
(00) 2 are the variances of time function and its Fourier transform respectively.
An important parameter of a window function is its size (or scale). The selection
of an appropriate window size poses a fundamental problem in signal analysis. Thus, by
varying the window function used, one can trade the resolution in time for the resolution
in frequency. An intuitive way to achieve this is to have short time duration high
frequency basis functions, and long time duration low frequency ones. Fortunately, the
wavelet transform provides for this desired feature and is defined as,
where a E ,b E R . Here a, and b are the scale and shift variables respectively, and
they are continuous variables. Depending on the scaling parameter a, the wavelet
function ψ(t) dilates or contracts in time and causing the corresponding contraction or
dilation in the frequency domain. Therefore a flexible time-frequency resolution is
achievable with the wavelet transforms. Another significant difference of these
transforms is that, the STFT is never a real function on the time-frequency plane
regardless of the choice of ω(t) , but the wavelet transform is real if the basic wavelet
WO is chosen to be real.
3.4.1 Continuous Wavelet Transform
The continuous wavelet transform maps a function f (t) onto time-scale space as
ψab(t) represents a family of functions obtained from a single wavelet function ψ(t) and
the dilation and translation parameters a and b as
where a and b are continuous.
The wavelet function ψ(t) is a band-pass function. It is desired that this function
have a good time and frequency localization so that f (t) is decomposed into elementary
building blocks which are jointly well localized in time and frequency. The wavelet
function has to satisfy the "admissibility" condition that makes it an isometry (reflection
or a half turn rotation) of L2 (R) onto E (R x R) . This requirement limits the wavelet
functions which must satisfy
where ψ(Ω) is the Fourier transform of the wavelet function ψ(t). The admissibility
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condition is directly related to the decay of the wavelet function t) which is required
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to have good localization. The admissibility condition for a continuous ψ(Ω) is
equivalent to a zero-mean wavelet function in time
This condition forces that the wavelet function is a band pass function and decays at
least as fast as Itl e in time (in practice we need to have much faster decay of ψ(t), in
order to have good time localization).
The admissibility condition assures that the "resolution of the identity" holds.
This guarantees that any function f (t) E L2 (R") can be reconstructed from the wavelet
space as
where the wavelet coefficients were defined earlier in Eq. (3.17). Whenever ψ(t) is a
real function, the integral limits of Ch expression in Eq. (3.22) are changed from 0 to 00.
Resolution of the identity ensures that the Continuous Wavelet Transform
(CWT) is complete if Wf (a,b) are known for all a and b. A continuous signal f (t) is
represented by a pass band function ψ(t)and its dilated and translated versions. The
dilation in time leads to different resolutions in frequency. Fig. 3.6 displays a wavelet
function ψ(t) and its dilations for different values of parameter "a" along with their
Fourier transforms. This figure helps to visualize the time-frequency plane and
emphasizes the band pass nature of ψ(t) and its dilations. Fig. 3.3 also displays the
time-frequency resolution cells of the wavelet transform compared with the STFT. This
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figure indicates the fixed time-frequency resolution of the STFT versus the more flexible
resolution of the wavelet transforms.
Figure 3.6 The time-frequency plane resolution cells of the STFT vs. Wavelet transform
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The STFT yields the deposition of a signal into a set of equal bandwidth
functions sweeping the entire frequency spectrum. On the other hand the wavelet
transform provides the decomposition of a signal by a set of constant Q (or equal
bandwidth on a logarithmic scale) band pass functions. The constant bandwidth
condition on a logarithmic scale can be easily seen by the following relation,
The roles played by the transform parameters are different for STFT and wavelet
transforms. The time parameter r in the STFT refers to actual time instant, while the
parameter b in the continuous wavelet transform refers to the time instant lb .
a
There is a time-frequency resolution trade-off in the wavelet transform. To
quantify how the continuous wavelet transform spans the time-frequency plane, the
measures of time and frequency resolutions are defined. Let at and an be the standard
deviations of the mother wavelet function  ψ (t) in the time and frequency domains
respectively and the corresponding variances are defined as




0v(—)  centered at (t0 ,---9-) with the variances
a	 a
These results explain the role of scaling parameter a in the wavelet transform. Fig. 3.7
displays time-frequency resolutions of the wavelet and scaling functions for different
values of a.
Figure 3.7 The role of scaling parameter in wavelet transform
3.4.2 Parseval Relation of Wavelet Transforms (Energy Preservation Property)
We will now show that the Parseval relation in the wavelet transform
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holds for any signal f (t) which is squared-integrable.	 Its proof requires the
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admissibility condition, which was defined in Eq. (3.20). By using the dual relation of
one can get
It is worth noting that the wavelet transform energy between the different scales also
preserves such that
3.4.3 Discrete Wavelet Transform
Although the admissibility condition assures the complete representation of f (t) with its
wavelet transform coefficients W f (a,b) , it requires the wavelet transform operation to
be performed for all values of a and b which are continuous parameters. This transform
representation is not practical. One would prefer to perform the wavelet transform
operation as few times as possible. Therefore these scaling or dilation, and translation or
shift parameters, a and b respectively, are discretized. This discretization provides a
transform grid or frame on the time-scale plane for the representation of signal f (t) . It
is intuitive that this grid or frame should be defined properly such that the complete
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representation of f (t) is still possible. This is called the Discrete Wavelet Transform
(DWT). This version of the wavelet transform reduces the redundancies of the wavelet
space W1 (a,b) significantly. The mathematical reasoning on the choice of frames or
grids is perfectly treated in the literature [22].
Now we can define the basis functions of a Discrete Wavelet Transform as the
subset of continuous wavelet function
with the corresponding discrete transform lattices or grids
Hence, the discrete wavelet transform basis functions can be expressed as
Here m and n are integers. It is intuitively seen that this discrete wavelet family
approaches to a continuous wavelet family when a o -1 	 b0 --> 0
It can be shown that the functions of a discrete wavelet transform basis
ψmn(t) can form a frame or the sets of m and n parameters are proper for the
completeness if the wavelet function ψ(t) satisfies the admissibility condition. Then the
frame bounds are constrained by the inequalities 0<A<B<G0
These inequalities hold for any choice of a0 and bo . These bounds diverge for non-
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admissible wavelet functions.
The discrete wavelet transform is defined on the grid points or in the frame of
time-scale plane as
W f (m,n)	 f >= a0^2 ψ(a0^-m t — nb0̂ )f (t)dt	 (3.36)
and the wavelet transform representation of the signal
f (t) = EEwf (n,n)Knn (t)	 (3.37)
m n
There is a particular interest on binary or dyadic grid where a0 = 2 and b0 =1, which





The sleep apnea data were acquired from the Pulmonary Function Test (PFT) Lab at
the New York Presbyterian Hospital (Columbia Presbyterian Medical Center) and the
normal subjects data were acquired from the NJIT Biomedical Engineering Signal
Processing Research Lab. A total of 22 subjects (18 males and 4 females, 49 ± 20 years)
experiencing both OSA and CSA in whom sleep-disordered breathing were diagnosed,
were used for this thesis. The inclusion criterion was the presence of at least five OSA
per hour of sleep. The severity of the disorder, from moderate to severe, was based on
the apnea / hypopnea index (the number of apneas / hypopneas per hour of sleep).
Chronic hypertension was present in 14 subjects and none of them were treated for
hypertension. Three subjects were current smokers.
The gold standard for a definitive diagnosis of the sleep apnea / hypoapnea
syndrome is polysomnography (PSG) [9]. Polysomnography is a scientific evaluation of
sleep. A polysomnograph is a machine that converts physiological signals (Ex. Oxygen
saturation, Airflow, EEG, ECG, blood pressure, thoracic and abdominal movement) in
the body to a graphical representation, which can help determine what is occurring
during sleep. The subjects were chosen from the patients who came with the complaint
of the following: snoring, poor sleep quality, excessive daytime sleep, some degree of




Each subject underwent overnight polysomnography (PSG). PSG measures included
thoracic and abdominal wall expansion, oro-nasal airflow, oximetry, body position,
ECG, blood pressure and two-channel electroencephalography. EEG arousal was
defined as an abrupt and discrete change in EEG frequency. Sleep stage analysis was
performed by a sleep specialist. All subjects reported to the Sleep Laboratory at 20:00
and underwent standard nocturnal polysomnography until 06:00 the following morning.
Typically a full night's sleep is observed before a diagnosis is reached, and in some
patients a second night's recording is required. Because of the number and variety of
measurement made, this test is somewhat uncomfortable for the patient [3].
4.3 Sleep Recordings
Sleep was recorded using standard polysomnographic measurements including
electroencephalography (EEG), Electrocardiography (ECG) with precordial surface
electrodes, oxyhemoglobin saturation 02 with finger pulse oximeter (Embla, type XN),
blood pressure, nasal and oral airflow measured by thermistors. respiratory movements
of the rib cage and abdomen with piezo sensor bands. We recorded two leads of EEG,
ECG, nasal airflow, thoracic and abdominal respiratory movements, oxygen saturation,
snoring and body position. All sleep recordings were attended by a sleep specialist,
which took care of the patients and electrodes during the night. We recorded at least
eight continuous hours from 20:00 to 06:00. Data were recorded using the Labview Link
15 program, digital data with 200 Hz sampling rate for the ECG, blood pressure and
EEG with 16 bit resolution. Respiration, airflow and oxygen saturation were digitized at
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sampling rates of 10 Hz. All signal data were stored in the .TXT format, which allows
easy exchange with other programs to display the signals and gives access to many
analysis tools.
4.4 Data Analysis
The raw data was analyzed by using the LabVIEW (weighted coherence, Fig: 4.1)
program and the output was stored in .asc file format. From this output the time-
frequency (Wavelet) analysis was performed to determine the sympathetic and
sympatho-vagal activities.Block
 Diagram
(Fig: 4.1) LabVIEW Program for power spectrum analysis.
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4.4.1 Power Spectrum Analysis
The acquired digital data was transferred to a signal-processing computer. The raw data
was run with a channel identification program (LabVIEW, Fig: 4.2) to identify the
channels and locate the period of apnea.
The following (Fig: 4.3) represents the output of the channel identification program.
1 St graph - Oxyhemoglobin saturation (Sa02)
2nd graph - Thoracic movement
3 rd graph — Abdominal movement
4 th graph — Airflow
5 th graph — Electrocardiograph (ECG)
6 th graph — Blood pressure (BP)
Block Diagram
(Fig: 4.2) LabVIEW program for channel identification.
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(Fig: 4.3) LabVIEW Program to identify the channels of apnea subject (KT).
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Another LabView (weighted coherence, Fig: 4.1) program was used to obtain the HRV
power spectrum. The following is a description of the necessary steps to obtain the
power spectrum of HRV.
The first step to obtain the power spectrum of HRV is to detect every R-wave in the
ECG. Because the R-wave complex is pronounced in the ECG, the LabVIEW detection
program can easily detect these R-waves. If an error occurs during the R-wave detection,
existing software can be used to manually detect or undetect the incorrectly detected R-
waves.
The IBI signal represents the heart period at discrete points. It is not suitable for FFT
analysis because the discrete points, located at each R-wave, are not evenly spaced. In
order to produce equidistant IBI samples suitable for analysis, the IBI signal must be
interpolated. The interpolation method used is that of a backward step function. After
the IIBI signal is obtained, it is stored in .asc format to run with the Wavelet program.
The IIBI signal is illustrated in Fig: 4.4.Detrended
 I IIBI 1:71,-t+ of 2 HR asc using  meld wavelet
(Fig: 4.4) IIBI Plot of apnea subject (KT) using Morlet Wavelet.
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4.4.2 Wavelet Analysis
After opening the Wavelet program (Appendix B) version 6.1, type the root directory
file .asc location and then type wl_apnea to access the Wavelet program. The program
will ask to enter the sampling frequency, no of windows to open, and the type of wavelet
need to use. In our analysis we used Morl Wavelet. It opens up the specified number of
windows; the last three windows give us the useful information for the investigation of
sleep apnea. (Fig: 4.5) represents the sympathetic and parasympathetic activities of an
apnea subject, and (Fig: 4.6) represents the normalized value of sympathetic and
parasympathetic activities of an apnea subject.
(Fig: 4.5) Sympathetic and Parasympathetic activity of apnea subject (KT).
4.4.3 Sleep Recording of Control Subjects
In order to compare our results with normal subjects 5 healthy persons participated in
the study in the age group of (25±5). These normal controls had no symptoms of
sleepiness and no sleep apnea. The normal subjects data were acquired at the New
Jersey Institute of Technology Biomedical Engineering lab. Five channels of
physiological signals were acquired from the normal subjects, which include two
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channels of EEG, one channel of ECG, continuous Blood Pressure and thoracic
respiratory movements.
The EEG signal was acquired with a Grass amplifier (Grass Telefactor
W.Warwick, R.I. USA), the ECG signal acquired using Resp-I Impedance Pneumograph
(UFI, Morrobay, California), the blood pressure acquired using Colin 7000 continuous
blood pressure monitor (Colin Medical Instruments Corp., San Antonio, Texas) and the
thoracic respiratory movements were recorded with a chest belt using inductive
plethysmography (Respitrace, Studley Data Systems, Oxford, U.K.).
(Fig: 4.7) Equipment setup for the normal subject data acquisition.
The ECG and EEG leads were hooked up to the subject using disposable
electrodes and continuous blood pressure monitor cuff kept on the arm. When the
subject was ready to sleep the lead connections were checked and the light was turned
off. The acquired analogue signals were amplified by the corresponding instrument.
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From the data acquisition instrument the amplified signals were transferred to the
Laptop through the interface board and DAQ card.
The data were digitized with 200 Hz sampling rate for the ECG, blood pressure,
respiration and EEG with 12 bit resolution. The digitized data were recorded in a
computer for subsequent analysis using the Labview (Link 15) program. All signal data
were stored in the .TXT format, which allows easy exchange with other programs to
display the signals and gives access to many analysis tools. Further analysis of normal




The investigation of the heart rate variability during sleep apnea was performed
through power spectral analysis and wavelet analysis. The changes in power spectral
components LF, HF & LF/HF have been described by comparing the normal subjects
with apnea subjects. From the spectral analysis of each subject, the LF and HF were
averaged to 5 minutes. From the average of LF and HF values the mean was calculated.
In our study we found that there is a statistically significant difference in sample means
of sympatho-vagal balance (LF/HF) between normal and sleep apnea subjects. That is,
the sampled subjects from the normal and apnea populations were found to be
significantly different in their mean values (p< 0.05) by a two-sample t-test (Appendix
E). In order to check the difference between the individual groups, t-tests were applied.
Statistical significance was stated for p< 0.05. In Fig: 5.1 & 5.2 we observed an increase
in LF & HF activity in apnea subjects compared to normal subjects, but the difference in
sample means were not found to be statistically significant. This increase in LF & HF
could be because of the presence of an autonomic dysfunction in sleep apnea patients, or
one apnea subject (PW) (Fig: 5.1 and 5.2) having large variation in spectral power
compared to the others may cause this variation.
t-test for normal and apnea subjects
DataSet MEAN (N) MEAN (A) t p
(N = 6) (N = 7)
LF 179.87 1024.89 -1.61 0.07
HF 214.5 764.14 -0.82 0.22
LF/HF 1.57 6.52
-2.84 0.01*
*: Significant at 0.05	 (with outlier - PW)
(Table: 5.1) The significance levels were given for the group difference between normal
and apnea subjects using the t-test.
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(Fig: 5.1) Comparison of LF (Normal Subjects Vs. Apnea Subjects).
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(Fig: 5.2) Comparison of HF (Normal Subjects Vs. Apnea Subjects).
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Fig: 5.3. Shows the comparison of LF/HF between the normal and apnea
subjects. The mean was investigated during sleep in normal subjects and sleep apnea
subjects (Table: 5.1). The LF/HF was significantly higher (p< 0.01) in sleep apnea
patients as we confirmed in our study (Fig: 5.3). (Table: 5.1) shows a greater decrease of
parasympathetic activity (HF) than the decrease of LF activity in sleep apnea patients [8]
[35].
(Fig: 5.3) Comparison of LF/HF (Normal Subjects Vs. Apnea Subjects).
In (Fig: 5.1 & 5.2) one apnea subject has a large variation in LF & HF compared to the
rest of the subjects, and therefore could be an outlier. Therefore we did the t-test without
that person (PW). We observed (Table: 5.2, Fig: 5.4 & 5.5) increased LF in sleep apnea
subjects compared to normal subjects and decreased HF in sleep apnea subjects
compared to normal subjects.
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t-test for normal and apnea subjects







HF 214.5 103.5 1.4 0.09
LF/HF 1.57 7.46
-3.5 0.002*
(Without outlier - PW)*: Significant at 0.05
(Table: 5.2) The significance levels were given for the group difference between normal
and apnea subjects using the t-test.
(Fig: 5.4) Comparison of LF (Normal Subjects Vs. Apnea Subjects)
Penzel et al. [35] investigated spectral components in normal and sleep apnea
subjects. The LF component decreases in normals compared to sleep apnea subjects and
the HF increases in normals compared to sleep apnea subjects. In our data the LF
(p<0.03) spectral component is significantly different in normal subjects compared to
the sleep apnea subjects and there is no significant difference in the HF component
(Table: 5.2).
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(Fig: 5.5) Comparison of HF (Normal Subjects Vs. Apnea Subjects)
(Fig: 5.6) Comparison of LF/HF (Normal Subjects Vs. Apnea Subjects)
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The LF/HF was investigated without the outlier apnea subject (PW); the t-test
showed the sample mean to be significantly different (p< 0.002) in normal subjects
compared to the sleep apnea subjects (Table: 5.2).
We compared the wavelet output of two different sleep apnea subjects, and
found that the amplitude changes in the IIBI plot were not the same (Fig: 5.8.b & 5.9.b).
This could be because different persons have different disease conditions other than
sleep apnea. (Fig: 5.8.a) shows the airflow with multiple apnea and (Fig 5.8.b) shows the
IIBI plot of the wavelet output in (Fig: 5.8.a). The airflow (top tracing) illustrates an
apnea where the respiratory efforts continue against the obstruction until the patient
arouses and respiration is resumed (Fig: 5.7). The wavelet output in Fig: 5.8.b (IIBI-
Plot) has an increase and decrease in amplitude corresponding to the apnea period in the
airflow graph.
(Fig: 5.7) shows the obstructive apnea for a period of 10 Sec.
(Fig: 5.8.a) Shows airflow of Apnea subject (HL).
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Time (sec)
(Fig: 5.8.b) Shows wavelet output of Apnea subject (HL) in (Fig: 5.8.a).
(Fig: 5.9.b) Shows wavelet output of apnea subject (SE) in (Fig: 5.9.b).
The data contained many spikes/glitches (increase and decrease in waveform
amplitude) [32], partially due to repetitive apneas and accompanied by respiratory flow.
In this example (Fig: 5.8.b), the apnea is characterized by slow rise in the heart rate
followed by a rapid decrease. (Fig: 5.9.b) shows another typical pattern for a different
subject in the heart signal during the onset of apnea. Unlike (Fig: 5.8.b), the episodes of
apnea in this signal are characterized by a rapid increase in the heart rate followed by a
slow decline. When comparing our results with previous studies, we confirmed that the
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heart rate variation differs from person to person as every person has different
physiological phenomena [32].
When we compared two different subjects (Fig: 5.8.a & Fig: 5.9.a), both had
multiple apneas, but their IIBI plot trends were not the same. Since each subject had
multiple apneas, we were unable to identify which apnea effect made an increase and
decrease in amplitude in the IIBI plot. Therefore we decided to look at a person who had
a normal pattern of sleep with a single apnea over a 5-minute duration. We did not have
such data from the sleep apnea data set, so we did the data acquisition in our research
lab. In this study six normal subjects were chosen in the age group of 25 ±3 years. After
the data acquisition we did the data analysis and found that all the normal subjects also
had an apnea [23]. Such a case is shown in (Fig: 5.10) and (Appendix C).
Fig: 5.10 has six channels; the first channel represents the oxygen saturation
(SaO2), the second channel represents the thoracic movement, the third channel
represents the abdominal movement, the fourth channel represents the airflow, the fifth
channel represents the electrocardiogram (ECG) and the sixth channel represents the
blood pressure (BP). In the graph (Fig: 5.10) we first observed a large oscillation in the
oxygen saturation and a single central apnea (no chest or abdominal wall expansion
during apnea) for a period of 10 seconds. (Fig: 5.11) shows an expanded version of (Fig:
5.10) in the vicinity of the apnea (135 to 145 seconds) that results from the obstruction
period of respiration. During a central apnea there is little to no chest or abdominal wall
expansion; therefore no negative intrathoracic pressure developed during the apnea [1].
In addition we observed that the inspiratory efforts against an occluded upper airway
produce large negative intrathoracic pressure swings, which is known to cause vagal
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activation. This is illustrated in the fifth channel (ECG) of (Fig: 5.11), where a
lengthening of R-R intervals in the ECG trace is witnessed during the apnea [1]. The
arousal at the termination of an apnea initiates a burst of sympathetic activity and the
transient sympathetic increases have been demonstrated by blood pressure and heart rate
(shown in Fig: 5.11 in the fifth and sixth channel (31000 to 32000 seconds)).
(Fig: 5.10) Normal subject (L2) with a single central apnea over 5-minute duration.
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(Fig: 5.11) is an expanded version of (Fig: 5.10) in the vicinity of the apnea (L2)
(135 — 145 Seconds).
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(Fig: 5.12) shows the IIBI Plot of (Fig: 5.11) normal subject (L2) with single
apnea over five minute duration.
Fig: 5.12 shows the IIBI plot of Fig: 5.11. The IIBI trend in (Fig: 5.12) shows a
sudden increase in HR (after 150 sec) at the end of the apnea to terminate the apnea and
resume the normal breathing. In the wavelet output, (Fig: 5.13) there is not much change
in the LF/HF ratio during the apnea period compared to the rest of the interval. To get
this kind of subject (one apnea over five minutes) is very difficult and this doesn't fulfill
the criteria of a sleep apnea subject [1].
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(Fig: 5.13) shows the wavelet output of normal subject (L2) with single apnea in
5 min duration in (Fig: 5.11).
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Drinnan [28] reported that patients with sleep apnea have significant regular dips
in the R-R interval plot, which are not present in the normal subject. Also, Drinnan [28]
studies shows that patients with sleep apnea tended to have a spectral peak lying
between 0.01 and 0.05 cycles / beat, with the width of the peak indicating variability in
the recurrence rate of the apnea, which are not present in the normal subject. When
comparing our results of a sleep apnea subject with a normal subject, all the apnea
(Appendix D) subjects had spectral peak at 0.01 and 0.05 Hz. [see (Fig: 5.14)], which is
not present in the normal subject (Fig: 5.15).
(Fig: 5.14) Spectral output of a sleep apnea subject (HL).
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(Fig: 5.15) Spectral output of a normal subject (GN).
In our study, out of five normal subjects, one subject does not have the spectral
peak, but rest of the normal subjects had spectral peaks at 0.01 and 0.05 Hz. which can
be seen in (Fig: 5.16 and 5.17). This may be because the normal subject had different
diseases other than sleep apnea. For the purpose of comparison we kept the arbitrary
units of the "power" axis constant for all spectral plots. Drinnan [28], study the X-axis is
represented in cycles/beat, but in our study the X-axis is represented in Hz in the spectral
output graph, This might be a reason that our result differs from the result of the
literature [28].
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(Fig: 5.17) Spectral output of a normal subject (L).
CHAPTER 6
CONCLUSION
Due to the complexity of the patterns and variations among subjects (Fig:
5.8.a & 5.9.a), we found that the LF: HF ratio oscillated in each case (Appendix E). It is
well known, for example, the sympathetic activity is increased during wakefulness and
physical activity, whereas parasympathetic activity dominates during sleep [1]. There is
also a clear difference in LF and HF spectral power and in their ratios during normal
sleep and sleep apnea. Transient physiological phenomena, such as body movements
and K-complexes during sleep, also results in altered HRV [5]. The gold standard in
diagnosing sleep apnea is polysomnography, an inconvenient, expensive and time-
consuming procedure [7]. Screening for SA using the ECG alone would save time,
money, and discomfort. When comparing our results with previous studies on HRV
during apnea, we can confirm several aspects with existing results.
When comparing two different subjects, the amplitude changes in the IIBI plot
were not the same (Fig: 5.8.b & 5.9.b). This could be because different persons have
different physiological phenomena other than sleep apnea. The data contained many
spikes/glitches (increase/decrease in waveform amplitude), partially due to repetitive
apneas and accompanied by respiratory flow. The sleep apnea (Fig: 5.8.b) is
characterized a by slow rise in the heart rate followed by a rapid decrease. (Fig: 5.9.a),
shows another typical pattern in the heart signal during the onset of apnea. Unlike
(Fig: 5.8.b), the episodes of apnea in this signal are characterized by a rapid increase in
the heart rate followed by a slow decline.
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In a subject with a central apnea there is little to no chest or abdominal wall
expansion; therefore no negative intrathoracic pressure developed during the apnea. In
addition (Fig: 5.7 — Effort Esophageal pressure) we observed that the inspiratory efforts
against an occluded upper airway produce large negative intrathoracic pressure swings
because of vagal activation. The lengthening/shortening of R-R intervals in the ECG
trace is witnessed during the apnea (Fig: 5.11) [1]. The termination of an apnea initiates
a burst of sympathetic activity and the transient sympathetic increases have been
demonstrated by blood pressure and heart rate. On the wavelet output, (Fig: 5.13) there
is not much change in the LF/HF ratio during the apnea period as compared to the rest of
the interval.
With reference to article [28], patients with sleep apnea tended to have a
spectral peak lying between 0.01 and 0.05 cycles / beat, with the width of the spectral
peak indicating variability in the recurrence rate of the apnea, which are not present in
the normal subjects. This statement was not satisfied with our data, since there is no
spectral peak at 0.01 and 0.05 Hz in all normal subjects. This might be because the X-
axis representations were not same. We represented the X-axis in Hz, but the literature
representing the X-axis in cycles/beat.
The changes in power spectral components have been described by LF, HF &
LF/HF [35]. We found the LF (p<0.03) spectral component is significantly decreased in
normal subjects compared to the sleep apnea subjects and there is no significant
difference in the HF (p<0.09) component (Table: 5.2). However there is a trend toward a
decrease in the HF component from the mean (N) of normal subjects to the mean (A) of
sleep apnea subjects. Since there is a decrease in the HF component (not significant) and
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a significant increase in the LF component. We hypothesize that there is an increase in
sympathetic activity in sleep apnea subjects compared to normal subjects. The mean (A)
of the HF component is lower than the mean (N) of the LF component for the apnea
subjects, which is not the case in normal sleep subjects and we concluded that an
autonomic dysfunction is present in patients with sleep apnea. The LF/HF investigation
(student t-test) showed the sample mean to be statistically significantly lower (p< 0.002)
in normal subjects compared to the sleep apnea subjects (Table: 5.2) [8][32]. This again
shows a significant increase in the sympatho-vagal balance in apnea subjects. Studies
show that either weight loss or CPAP (Continuous Positive Airway Pressure) is the best
treatment and indicate a significant improvement from the sleep apnea disease in the
cardiovascular point of view (To increase the ability of the heart muscle to contract and
supply enough blood to the metabolic need) [6]. Considerably more research is needed
to understand the effects and clinical relevance on total HRV power and its various
components in health and sleep apnea disease.
Future Work
1. Future work includes an investigation of stability and specificity in the
presence of other diseases known to affect the ANS as well as
different sleep stages, which will help in further investigation of
spectral components VLF, LF & HF.
2. Comparison of two different subject's result may not be a good idea
as each person has different physiological and cardiovascular
phenomena. It would be more interesting to compare the same
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person's data while the subject is in normal sleep and with sleep
apnea.
3. A correct detection of R peaks of the QRS complexes is believed to
require a sampling rate of 500-1000 Hz [35]. The sampling rate has to
be increased from the current 250 samples per second to provide finer
resolution in R wave peak detection.
4. To make these studies more objective, future data collection should be
done at the patient home. This could be a better solution, but its
disadvantage is an increase in experiment cost. The patients may not
feel comfortable in traveling to a sleep lab and hooked up with wires.
The traveling itself will cause discomfort to the patient's normal sleep
rather than sleep apnea. We need to find a better way of data
collection with the comfort of the patient in mind.
APPENDIX A
EQUIPMENT SETUP
The diagram below shows the laboratory setup for the Sleep recording experiments at
NJIT. The experienced technician setup all the leads and hock to the subject. When the
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APPENDIX B
COMPUTER PROGRAM
Time-Frequency Analysis using Wavelet
The following program used to analysis the sleep apnea signal.
% d_wvlet.m
% Matlab Wavelet Toolbox 2.0.
% Modified by D. Newandee
% 7-13-2001: using time - freq spectrogram and change to run with MATLAB 6.0
% 10-23-2001: add calculation of normalized sympathovagal ratio using chosen wavelet
% This program will accept any wavelet from the Matlab Wavelet Toolbox 2.0 by
entering the wavelet
% name in " for the 'wave' variable below.
clear all;
close all;

















sf=input('Please enter the sampling rate of the data --> ');
sf=sf/10;	 % upsampling (to get correct recording time)
%T=input('Please enter the window size in seconds --> '); % normally 10 (sec) is best
T=10.0;
nfft=input('Please enter the fft size (128, 256,512 etc.) --> '); % must be larger than
window size and in AA2
wave = input('Please enter name of wavelet used --> ','s');
x = decimate(rawdata,10); % decimate data array
N = length(x);	 % number of samples
%*sf = 1000;	 % sampling frequency
%*N = 500;	 % number of samples
%%T = 1/500;	 % window size in seconds (1/500 = 0.02 sec)
ws = T*sf;	 % window size in samples
%*nfft = 256;	 % fft size in specgram command. Must be larger than window
size in samples
%*wave = 'mexh'; 	 % the wavelet to use (see wavelets table in Matlab Wavelet
Tool Box v 2.0
t = ( (1:(N)) )* (1/sf); % times
f = ( (0:(N-1))/N) * sf; % frequencies
index = 1:N;
% first construct the time domain and frquency domain plots
fx = abs(fft(x));
% spectrum 1 D.m
% function [Pyy,f]=rspec(x,Fs)
fftsize=length(x);

































% construct a spectrogram with window size, ws
[B,frequencies,times] = specgram(x, nfft, sf, ws);








title(['Spectrogram with T =' num2str(1000*T) ' ms']);
%*orient landscape;
print -dps wvletb.eps









% now work out the scales at which to compute the CWT
% There is a connection between scale and frequency as follows
factor = 5/(2*pi);
% range of interested frequency
%freq = [100:100:2000]; % EMG: 100 - 2000 Hz
%freq = [1:10:100];	 % EEG: 1 - 100 Hz
freq = [0.01:0.01:2.0]; % HRV: 0.01 - 2 Hz
scale = factor * sf ./ freq;
% make sure the string wave is set before executing the m-file
% compute the CWT and plot at the same time
figure;
coef=cwt(x, scale, wave, 'plot');
title('scalogram - Scale vs. Time');
%* orient landscape;
%% print -dps wvletd.eps;




A=(I/sf)/60;	 % Time axis in minutes
m=512;	 % The size of the fft we will be computing.
skip=25;	 % Number of points we skip to get the next segment.












%LFC = input('Please enter the low frequency range in index numbers. ');
LFC=1:4;
symvag=sum(TFDs(LFC,1:k));


















axis('xy');	 % flip the vertical axis over
xlabel('Time (sec)');
ylabel('Frequency (Hz)');
title('Scalogram - Frequency vs. Time');
%* orient landscape;
print -dps wvlete.eps;
% make a 3D plot for better viewing, rotate by 45 degrees
figure;













title(['3D scalogram of ',eval('filename'),' using ',eval('wave'),' wavelet']);
%* orient landscape;
%* print -dps wvletf.eps;
subplot(2,1,2), contour(t, freq, abs(coef),20);




title(['Contour of ',eval('filename'),' using ',eval('wave'),' wavelet']);











%%axis([0 300 0 150]);
xlabel('Time (sec)');
ylabel('Frequency (Hz)');


























%order=input('Please enter the order of the lowpass filter. ');
%freq=input('Please enter the cuttoff frequency for LPF. ');



















































title('Ratio of LF to HF')
xlabel('Time (sec)');
ylabel('Amplitude');
%order=input('Please enter the order of the lowpass filter. ');
%freq=input('Please enter the cuttoff frequency for LPF. ');




















































t-test for normal and apnea subjects (with outlier - PW)
Normal Apnea Normal Apnea Normal Apnea
LF/HFName LF LF HF HF LF/HF
447.86 46.6 9.6
KT1 263.08 19.93 13.2
KT2 449.12 51 8.8
IL 1310.91 347.85 3.8
LY 386.38 108.54 3.6
PW 4045.19 4727.99 0.9
SF 271.74 47.1 5.8
LE 126.91 130 0.98
LES 343.53 151.8 2.263
SEK 110.67 23.39 4.731
AN 262.57 460.9 0.569
BV 81.98 259.64 0.315
BP4 153.59 261.29 0.581










t Critical one-tail 1.943180905
P(T<=t) two-tail 0.157398141












t Critical one-tail 1.943180905
P(T<=t) two-tail 0.440019861
t Critical two-tail 2.446913641










t Critical one-tail 1.85954832
P(T<=t) two-tail 0.021659048
t Critical two-tail 2.306005626
t-test for normal and apnea subjects (with outlier - PW
DataSet MEAN (N) MEAN (A) VARIANCE (N) VARIANCE (A) t P
LF 179.87 1024.89 10298.07 1903963.1 -1.61 0.07
HF 214.5 764.14 22506.89 3067773.8 -0.82 0.22
LF/HF 1.57 6.52 2.87 17.88 -2.84 0.01*
*: Significant at 0.05
t-test for normal and apnea subjects (without outlier - PW)
Normal Apnea Normal Apnea Normal Apnea 
LF/HFme LF LF HF HF LF/HF
AA 447.86 46.6 9.6
KT1 263.08 19.93 13.2
KT2 449.12 51 8.8
SIL 1310.91 347.85 3.8
LY 386.38 108.54 3.6
SF 271.74 47.1 5.8
LE 126.91 130 0.98
LES 343.53 151.8 2.263
EK 110.67 23.39 4.731
IAN 262.57 460.9 0.569
BV 81.98 259.64 0.315
)3134 153.59 261.29 0.581
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t Critical one-tail 1.812461505
P(T<=t) two-tail 0.067443708
t Critical two-tail 2.228139238











t Critical one-tail 1.812461505
P(T<=t) two-tail 0.191591326
t Critical two-tail 2.228139238
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t Critical one-tail 1.812461505
P(T<=t) two-tail 0.005665158
t Critical two-tail 2.228139238
t-test for normal and apnea subjects (without outlier - P







LF 179.87 521.51 10298.07 156249.64 -2.05 0.03
HF 214.5 103.5 22506.89 15178.21 1.4 0.09
LF/HF 1.57 7.46 2.87 14.07 -3.5 0.002*
*: Significant at 0.05
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